Drug Development

Articles

US Department of Health and Human Services announced a declaration to provide immunity to legal claims made in the US in relation to three investigational Ebola vaccines.

Legal Immunity Offered to Makers of Ebola Vaccines in the US

On December 8, Pfizer announced that it will establish a research program in gene therapy, and collaborate with Spark Therapeutics in Philadelphia, to develop potential gene therapy treatments for hemophilia.

Pfizer to Intensify AAV Vector Research in Gene Therapy for Hemophilia

Agnes Shanley is senior editor of Pharmaceutical Technology.

Sandoz announces their version of filgrastim, a follow-on biologic for the treatment of neutropenia, is as safe and effective as Amgen's Neupogen.

Sandoz's Biosimilar Shows Similarity to Amgen's Neupogen

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

No evidence that Fluad vaccine caused deaths in Italy, says EMA.

EMA Reassures Safety of Novartis Flu Vaccine

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Ranbaxy and Epirus announce the launch of India's first biosimilar for Remicade.

First Remicade Biosimilar Hits India

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Dual sourcing is one of many possible solutions to securing the supply chain.

Securing the Single-Use Supply Chain

Garrett Krushefski is scientific and technical services manager at SGM Biotech.

Craig A. Wallaceis senior technical specialist at 3M Infection Prevention Division, St. Paul, MN.

Kellie A. Matzinger is manager of Scientific & Technical Services at Mesa Laboratories.

Anthony M. Piotrkowski is regulatory manager at STERIS Corporation in Mentor, OH and co-chair of AAMI ST/WG 04 Biological indicators working group.

In anticipation of this mandatory switch from Oxyfume 2000 to 100% EtO for BI testing, comparison studies were performed to determine if the switch from Oxyfume 2000 to 100% EtO would have any impact on BI resistance label claims.

Effects of 100% Ethylene Oxide Test Gas on the Resistance of Ethylene Oxide Biological Indicators

Dalton Pharma Services announced it was awarded funding from ISTPCanada for its project to develop vaccines for respiratory syncytial virus and parainfluenza type 3.

Dalton Receives Funding for Development of RSV and Parainfluenza Type 3 Vaccines

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Manufacturers face regulatory overhaul, while brand-generic debates escalate over biosimilars and labeling changes.

Generic Drugs Face New Regulatory Future

Opdivo and investigational agent FPA008 will be tested in combination for their efficacy in boosting antitumor immune response.

Formulation and Drug Delivery